News | November 03, 2021
WHO issues emergency use listing for Covaxin
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
The agreement sharpens the company’s focus on priority medicines in respiratory & immunology portfolio
The Akovaz brand and generic market had U.S. sales of approximately US $ 67.5 million MAT for the most recent twelve months ending in August 2021
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended September 30, 2021
It provides an option to automatically perform nodule detection immediately after chest X-ray imaging
Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
Subscribe To Our Newsletter & Stay Updated
